Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 4th Quarter - Termination (No Activity)

LEADING BIOSCIENCES

via ML STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) · 2017Posted Apr 17, 2018Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: LEADING BIOSCIENCES
Description: Pharmaceutical company
Location: California · United States of America

Registrant

Firm: ML STRATEGIES, LLC
Description: Government relations consulting firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

LEADING BIOSCIENCES — Lobbying — Receipts Report